Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-020-20664-5
Affiliations:
6
Authors:
13
Institutions Authors Share
University of Pennsylvania (Penn), United States of America (USA)
9.000000
0.69
Genentech, Inc., United States of America (USA)
1.000000
0.08
Fox Chase Cancer Center (FCCC), Temple University, United States of America (USA)
1.000000
0.08
Health Sciences Center (HSC), Utah, United States of America (USA)
1.000000
0.08
Princeton University, United States of America (USA)
1.000000
0.08